BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34404904)

  • 1. Integrated multi-omics analysis of RB-loss identifies widespread cellular programming and synthetic weaknesses.
    Rajasekaran S; Siddiqui J; Rakijas J; Nicolay B; Lin C; Khan E; Patel R; Morris R; Wyler E; Boukhali M; Balasubramanyam J; Ranjith Kumar R; Van Rechem C; Vogel C; Elchuri SV; Landthaler M; Obermayer B; Haas W; Dyson N; Miles W
    Commun Biol; 2021 Aug; 4(1):977. PubMed ID: 34404904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the Transcriptional and Chromatin Accessibility Heterogeneity of Proliferating Cone Precursors in Human Retinoblastoma Tumors by Single Cell Sequencing-Opening Pathways to New Therapeutic Strategies?
    Collin J; Queen R; Zerti D; Steel DH; Bowen C; Parulekar M; Lako M
    Invest Ophthalmol Vis Sci; 2021 May; 62(6):18. PubMed ID: 34003213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
    Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
    Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RB1: a prototype tumor suppressor and an enigma.
    Dyson NJ
    Genes Dev; 2016 Jul; 30(13):1492-502. PubMed ID: 27401552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein Profiling of WERI-RB1 and Etoposide-Resistant WERI-ETOR Reveals New Insights into Topoisomerase Inhibitor Resistance in Retinoblastoma.
    Kakkassery V; Gemoll T; Kraemer MM; Sauer T; Tura A; Ranjbar M; Grisanti S; Joachim SC; Mergler S; Reinhard J
    Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pan-cancer molecular analysis of the RB tumor suppressor pathway.
    Knudsen ES; Nambiar R; Rosario SR; Smiraglia DJ; Goodrich DW; Witkiewicz AK
    Commun Biol; 2020 Apr; 3(1):158. PubMed ID: 32242058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of germline
    Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
    Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies.
    Tu J; Huo Z; Yu Y; Zhu D; Xu A; Huang MF; Hu R; Wang R; Gingold JA; Chen YH; Tsai KL; Forcioli-Conti NR; Huang SXL; Webb TR; Su J; Bazer DA; Jia P; Yustein JT; Wang LL; Hung MC; Zhao Z; Huff CD; Shen J; Zhao R; Lee DF
    Proc Natl Acad Sci U S A; 2022 Apr; 119(16):e2117857119. PubMed ID: 35412907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Oncogenic Transcription Factor Cooperation in RB-Deficient Cancer.
    Mandigo AC; Shafi AA; McCann JJ; Yuan W; Laufer TS; Bogdan D; Gallagher L; Dylgjeri E; Semenova G; Vasilevskaya IA; Schiewer MJ; McNair CM; de Bono JS; Knudsen KE
    Cancer Res; 2022 Jan; 82(2):221-234. PubMed ID: 34625422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of RB1 in human embryonic stem cell-derived retinal organoids.
    Zheng C; Schneider JW; Hsieh J
    Dev Biol; 2020 Jun; 462(2):197-207. PubMed ID: 32197890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour.
    Zhang H; Konjusha D; Rafati N; Tararuk T; Hallböök F
    Cell Oncol (Dordr); 2024 Feb; 47(1):209-227. PubMed ID: 37606819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability in retinoblastoma genome stability is driven by age and not heritability.
    Polski A; Xu L; Prabakar RK; Gai X; Kim JW; Shah R; Jubran R; Kuhn P; Cobrinik D; Hicks J; Berry JL
    Genes Chromosomes Cancer; 2020 Oct; 59(10):584-590. PubMed ID: 32390242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous identification of clinically relevant
    Xu L; Shen L; Polski A; Prabakar RK; Shah R; Jubran R; Kim JW; Biegel J; Kuhn P; Cobrinik D; Hicks J; Gai X; Berry JL
    Ophthalmic Genet; 2020 Dec; 41(6):526-532. PubMed ID: 32799607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis.
    Wang ME; Chen J; Lu Y; Bawcom AR; Wu J; Ou J; Asara JM; Armstrong AJ; Wang Q; Li L; Wang Y; Huang J; Chen M
    J Clin Invest; 2023 May; 133(10):. PubMed ID: 36928314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma.
    Salviat F; Gauthier-Villars M; Carton M; Cassoux N; Lumbroso-Le Rouic L; Dehainault C; Levy C; Golmard L; Aerts I; Doz F; Bonnet-Serrano F; Hayek S; Savignoni A; Stoppa-Lyonnet D; Houdayer C
    JAMA Ophthalmol; 2020 Aug; 138(8):843-850. PubMed ID: 32556071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
    Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE
    Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling Developmental and Tumorigenic Aspects of Trilateral Retinoblastoma via Human Embryonic Stem Cells.
    Avior Y; Lezmi E; Yanuka D; Benvenisty N
    Stem Cell Reports; 2017 May; 8(5):1354-1365. PubMed ID: 28392220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolite systems profiling identifies exploitable weaknesses in retinoblastoma.
    Sahoo S; Ravi Kumar RK; Nicolay B; Mohite O; Sivaraman K; Khetan V; Rishi P; Ganesan S; Subramanyan K; Raman K; Miles W; Elchuri SV
    FEBS Lett; 2019 Jan; 593(1):23-41. PubMed ID: 30417337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas.
    Xie C; Lu H; Nomura A; Hanse EA; Forster CL; Parker JB; Linden MA; Karasch C; Hallstrom TC
    Mol Cancer; 2015 Apr; 14():93. PubMed ID: 25907958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Use of rAAV2-RB1-Mediated Gene Therapy in Retinoblastoma.
    Shi H; He X; Yang Z; Liao Q; Ruan J; Ge S; Chai P; Jia R; Fan J; Wen X; Fan X
    Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):31. PubMed ID: 38133505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.